Neiges Biotechnologies
PrivateLast Round
Grant
Jun 22, 2026
Total Funding Raised
$10,000
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Neiges Biotechnologies operates in Healthcare & Life Sciences and is based in Montreal. It has raised $10,000.
Neiges Biotechnologies is a biotechnology company that develops human-derived organoid models of intestinal tissues to advance preclinical research and drug discovery for gastrointestinal therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neiges Biotechnologies Comparables
Compare Neiges Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Intero Biosystems | 93% | |
| Altis Biosystems | 83% | |
| Vivodyne | 79% |
For institutional investors. Book with your work email.
Neiges Biotechnologies Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Neiges Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Consortium Québécois sur la découverte du médicament | Grant |
| District 3 Innovation Center | Accelerator |
| Gouvernement du Québec | Grant |
| Front Row Ventures | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
Received grant funding from Consortium Québécois and Gouvernement du Québec.
For institutional investors. Book with your work email.
Neiges Biotechnologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Neiges Biotechnologies's valuation, stock price, and market status.
Is Neiges Biotechnologies a public or private company?
Neiges Biotechnologies is a private company.
What is the current stock price of Neiges Biotechnologies?
Neiges Biotechnologies is a private company, so its shares have no public market price. Caplight tracks Neiges Biotechnologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Neiges Biotechnologies worth (valuation)?
Valuation information for Neiges Biotechnologies is not publicly available.
Can I buy Neiges Biotechnologies stock?
Neiges Biotechnologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Neiges Biotechnologies's last funding round?
Neiges Biotechnologies's most recent funding round was Grant on June 22, 2026.
Who are the main investors in Neiges Biotechnologies?
Key investors in Neiges Biotechnologies include Consortium Québécois sur la découverte du médicament, District 3 Innovation Center, Gouvernement du Québec, Front Row Ventures.
Will Neiges Biotechnologies IPO soon?
No public IPO plans have been announced for Neiges Biotechnologies.
How can I track Neiges Biotechnologies secondary market activity?
Caplight tracks bids, offers, and trades in Neiges Biotechnologies's shares on secondary markets.